Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB

Open Access

Peer-reviewed

Research Article

Jason D. Bishai,

Affiliation School of Humanities and Sciences, Stanford University, Stanford, California, United States of America
⨯
William R. Bishai,

Affiliation Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America
⨯
David M. Bishai

* E-mail: dbishai@jhsph.edu

Affiliation Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯

Reader Comments (0)

Multi-drug-resistant tuberculosis
Is the Subject Area "Multi-drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Antigens
Is the Subject Area "Antigens" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Immunity
Is the Subject Area "Immunity" applicable to this article?

Thanks for your feedback.
Drug policy
Is the Subject Area "Drug policy" applicable to this article?

Thanks for your feedback.
Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis drug discovery
Is the Subject Area "Tuberculosis drug discovery" applicable to this article?

Thanks for your feedback.